Vident Advisory, LLC Vertex Pharmaceuticals Inc Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 7,996 shares of VRTX stock, worth $3.95 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,996
Previous 51,527
84.48%
Holding current value
$3.95 Million
Previous $21.5 Billion
82.6%
% of portfolio
0.1%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,716Shares Held
225MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.2 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.3 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.79 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.22 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $127B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...